Skip to main content
Clinical Trials/NL-OMON54244
NL-OMON54244
Recruiting
Phase 2

euroinflammation and post-infectious fatigue in individuals with and without Covid-19 - COVFATI

niversitair Medisch Centrum0 sites85 target enrollmentTBD
Conditionscorona10007951

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
corona
Sponsor
niversitair Medisch Centrum
Enrollment
85
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • Group 1\. In order to participate in this study, individuals with a previous
  • COVID\-19 infection and with post\-infectious fatigue or cognitive complaints
  • should meet the following criteria:
  • 1\) The patient was diagnosed with symptomatic COVID\-19, confirmed by a positive
  • PCR for SARS\-CoV\-2, positive SARS\-CoV\-2 serology or CO\-RADS (COVID\-19 Reporting
  • and Data System) 4 or 5 on CT\-scan, or antigen quicktest, or had typical
  • symptoms and was part of a household in which another person was tested
  • positive by PCR 2 weeks before or after the first day of illness;
  • 2\) The patient is 3 months after being diagnosed with COVID\-19 or after
  • hospital discharge in case the patient was admitted.

Exclusion Criteria

  • 1\) Rs6971 shows low affinity binding
  • 2\) Patients who are unable to lay still for scanning due to claustrophobia or
  • severe back pain or trypanophobia (fear of needles)
  • 3\) Gross neurological pathology (strategic or lobar infarcts) on MRI or CT that
  • may interfere with the interpretation of the PET scan.
  • 4\) Post\-infectious complaints before COVID\-19 or any other current disease of
  • infection that is known to cause substantial fatigue

Outcomes

Primary Outcomes

Not specified

Similar Trials